NTK’s position is that Daiichi Sankyo has caused losses by preventing it from proceeding with the open offers in respect of the company and Fortis Malar Hospitals, Fortis Healthcare said in a regulatory filing.
NTK is also seeking an injunction to prevent Daiichi from making defamatory remarks against it with respect to the aforesaid open offers, it noted.
“The Claims filed by NTK against Daiichi Sankyo are tort claims premised on the latter’s unlawful interference with NTK’s trade or business, conspiracy of Daiichi Sankyo and other persons, malicious falsehood and defamation under the applicable substantive laws,” IHH noted.
In November 2018, IHH had acquired, via a preferential allotment, a 31.17 per cent stake in Fortis by infusing a fresh capital of Rs 4,000 crore.
The IHH-Fortis deal is stuck due to a legal battle between Daiichi and the former promoters of Fortis Healthcare.